In the News

Alzheimer’s Research and Treatment Center

Dr. Watson, the world’s leading investigator for the Lecanemab compound, letter and statement on the FDA approval of Lecanemab.

We are all ecstatic here at ARTC with the approval of the Lecanemab. This is the first disease modifying treatment to be approved anywhere in the world. This approval comes through the dedication and commitment of Eisai pharmaceutical company, as well as the many investigators and Subjects who participated in the various programs for this compound since 2013.